Skip to main content
Clinical Trials/IRCT20200823048491N1
IRCT20200823048491N1
Completed
Phase 3

Evaluation of the effect of N-acetylcysteine ??(NAC) in cardio-pulmonary pump device in preventing kidney failure in coronary heart surgery

Esfahan University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Patients undergoing open heart surgery.
Sponsor
Esfahan University of Medical Sciences
Enrollment
100
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 40 to 65 years
  • GFR greater than 60
  • Creatinine less than 1\.5
  • Having conscious satisfaction
  • Patients with no previous history of open heart surgery
  • Patients undergoing CABG coronary artery bypass graft surgery
  • Patients who did not use ECMO and pump balloons before open heart surgery

Exclusion Criteria

  • Patients undergoing CABG without Cardiopulmonary pump (CPB)
  • Patients who had valve surgery in addition to CABG surgery
  • Patients who are candidates for emergency CABG

Outcomes

Primary Outcomes

Not specified

Similar Trials